Literature DB >> 23011835

Primary lymphoepithelioma-like carcinoma of the lung: report of a rare case and review of the literature.

Neşe Arzu Yener1, Ahmet Balikçi, Rahmi Çubuk, Ahmet Mıdı, Alpay Örkı, Aynur Eren Topkaya.   

Abstract

Primary lymphoepithelioma-like carcinoma of the lung is a rare type of non-small cell lung carcinoma. In this study, we aimed to present a 62-year-old smoker male with a primary lymphoepithelioma-like carcinoma of the hilar region of the left lung. The patient underwent left pneumonectomy and no adjuvant therapy was given. There were no other abnormalities on whole body PET/CT scan including the nasopharyngeal region. The patient showed seropositivity for EBV IgG but immunohistochemistry and PCR amplification studied on paraffin-embedded tissue sections of the tumor failed to show any sign of EBV infection within the tumor cells. He is alive and disease-free four months after the operation. Although primary lymphoepithelioma-like carcinoma of the lung is usually reported in young females with no history of tobacco use and the tumor cells are infected with EBV, it may rarely be seen in elderly males with a history of tobacco use and the tumor cells not infected with EBV.

Entities:  

Mesh:

Year:  2012        PMID: 23011835     DOI: 10.5146/tjpath.2012.01139

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  2 in total

1.  Primary pulmonary lymphoepithelioma-like carcinoma initially diagnosed as squamous metaplasia: A case report and literature review.

Authors:  Yasha Liang; Cheng Shen; Guowei Che; Fengming Luo
Journal:  Oncol Lett       Date:  2015-02-17       Impact factor: 2.967

Review 2.  Primary pulmonary lymphoepithelioma-like carcinoma accompanied by hypertrophic pulmonary osteoarthropathy in a non-epidemic region: a case report and literature review.

Authors:  Ning Zhu; Shanhong Lin; Ning Xu; Lei Chen; Zhenghua Piao; Chao Cao
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.